Kuleon

Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted treatments

placeSeattle, Washington, United States calendar_todayFounded 2021 groups5 employees language kuleonbio.com

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon